Navigation Links
Patients with Irritable Bowel Syndrome not more likely to develop polyps, colon cancer
Date:3/9/2010

Ann Arbor, Mich. Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology.

"Patients and doctors get nervous about the symptoms of irritable bowel syndrome (IBS)," says William D. Chey, M.D., professor of Internal Medicine at the University of Michigan Medical School. "They think the symptoms represent something more sinister."

"This study should reassure doctors and patients that typical IBS symptoms are not indicators of a more serious disease," he adds.

Chey was the lead author on the study, the largest prospective evaluation of the results of colonoscopies in patients with irritable bowel syndrome.

IBS symptoms include recurrent episodes of abdominal pain or cramping in connection with altered bowel habits. The condition affects 10 to 20 percent of the U.S. population and is more common among women than men. Many of those afflicted never seek treatment.

IBS patients often undergo colonoscopies because physicians are particularly concerned about missing colorectal cancer or inflammatory bowel diseases like ulcerative colitis or Crohn's disease, Chey says. Roughly a quarter of all colonoscopies performed in the U.S. are for IBS-related symptoms.

This research shows that it is unnecessary to order colonoscopies for IBS patients, unless they show other alarming symptoms like unexplained weight loss or anemia, bleeding from the GI tract, or have a family history of colon cancer, inflammatory bowel disease or celiac disease, says Chey, who also is director of U-M's Gastrointestinal Physiology Laboratory and the Michigan Bowel Control Program.

"Lay people and doctors overuse colonoscopies, which are very expensive procedures, in patients with typical IBS symptoms and no alarm features. Of course, patients over the age of 50 years or who have alarm features should undergo colonoscopy to screen for polyps and colon cancer." Chey says.

Chey's research also showed that a small percentage of IBS patients older than 35 (2.5%) had an unusual disease called microscopic colitis. Microscopic colitis can masquerade as IBS in patients with diarrhea and is important to diagnose because it is treated differently than IBS, he says.


'/>"/>

Contact: Mary Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related biology news :

1. Dietary supplements discouraged for prostate cancer patients
2. New cancer treatment gives hope to lymphoma and leukemia patients
3. Enzyme deficiency protects hepatitis C patients from treatment-related anemia
4. Stent grafts top gold standard balloon angioplasty for dialysis patients
5. Predicting prognosis and treatment response in a subset of pancreatic cancer patients
6. Test could predict which idiopathic pulmonary fibrosis patients will become severely ill
7. Simulation study may help Parkinsons patients retain driving skills
8. Most patients gain weight after getting a new knee, UD study finds
9. New method improves eating skills of dementia patients
10. Disease severity in H1N1 patients
11. Brain abnormalities in Parkinsons patients develop before symptoms occur
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOGĀ“s multi-biometrics system.   Continue ... ...
(Date:3/16/2017)... HANOVER, Germany , March 16, 2017 CeBIT 2017 - Against ... Continue Reading ... Used combined in one project, multi-biometric solutions ... ... Identification Systems) ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
(Date:3/22/2017)... 22, 2017 /PRNewswire/ - FACIT announced a seed ... "Propellon"), a start-up created by FACIT focused on ... investment, combined with non-dilutive capital, achieves a targeted ... funding enables Propellon to accelerate the nomination of ... financing and/or entering a strategic partnership for clinical ...
(Date:3/22/2017)... , March 22, 2017   VWR ... provider of product and service solutions to ... it has acquired EPL Archives, Inc., an ... across the entire regulated product research, development ... document storage and ancillary services. EPL Archives ...
Breaking Biology Technology: